Treatment with ITD1 significantly attenuated the AML-exos-induced proliferation and migration of Thp-1 cells (Figure 5D,E), underscoring the critical contribution of exosomal TGF-β to leukemic cell behavior. The gene discussed is GLI2; the disease is acute myeloid leukemia.